Athersys (ATHX) – FDA
-
Athersys (ATHX) Granted Clinical Type B Meeting with FDA for MASTERS-2 Clinical Trial Protocol Discussion
-
Athersys (ATHX) Announces Favorable Preclinical Results for MultiStem Treatment in Defense Department Radiation Countermeasure Study
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ATHX Stock Lookup